Top Premarket Gainers

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

08:48 AM EDT, 04/14/2025 (MT Newswires) -- Third Harmonic Bio ( THRD ) shares rose 40% in recent Monday premarket activity, after saying its board has approved a plan for the company's liquidation and dissolution and will seek stockholder approval for the plan at its annual meeting on June 5.

Verve Therapeutics ( VERV ) stock climbed 23% after it reported positive initial results from its phase 1b Heart-2 clinical study to evaluate gene editing therapy VERVE-102 for patients with heterozygous familial hypercholesterolemia and premature coronary artery disease.

Palatin Technologies ( PTN ) shares were up 22% after the biopharmaceutical company said it appealed the New York Stock Exchange's decision to delist its common shares.

Apple ( AAPL ) shares rose 6.4% after KeyBanc upgraded it to sector weight from underweight, followed by a Counterpoint Research report saying that the tech giant was Q1's top seller in the global smartphone market with a 19% market share, aided by the launch of the iPhone 16e and continued growth in its non-core markets.

BP (BP) stock gained more than 3% after the energy giant said it has made an oil discovery at the Far South prospect in deep water in the 'Gulf of America.'

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.